APPLICATION
ANDA207548
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-08
LATEST ACTION
2022-12-14
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
LEVOLEUCOVORIN CALCIUMDiscontinued
LEVOLEUCOVORIN CALCIUM EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) · SOLUTION · INTRAVENOUS
Approval history
2022-12-14Labeling · Supplement 1 · standardAP
2022-12-14Labeling · Supplement 5 · standardAP
2017-09-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.